Therapiemöglichkeiten in der platinresistenten Situation – Prof. Heitz und Fr. Kaiser im Interview

In this excerpt from our interview for World Ovarian Cancer Day 2026, Dr. Heitz and Ms. Kaiser (Evangelical Hospitals Essen-Mitte) discuss the importance of molecular testing and new drugs in the treatment of ovarian cancer. What you can expect in this interview: Important markers: Learn more about the folate receptor, CPS score, and HER2, and their significance for your therapy. New hope through TDXD: We explore the use of antibody-drug conjugates, originally developed for breast cancer therapy. The path to treatment: Tips for discussing treatment with your doctors and information on insurance coverage. Watch the full interview now on our channel! 📺 A second opinion can offer you more options and thus a better quality of life. About us: The Ovarian Cancer Foundation is committed to improving awareness and care for those affected by ovarian cancer. Please support us by subscribing or liking our channel! ... #OvarianCancer #Medicine #SecondOpinion #Oncology #PatientAdvice #WorldOvarianCancerDay2026